Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Shares Outstanding (Weighted Average) (2022 - 2023)

Historic Shares Outstanding (Weighted Average) for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $1.6 million.

  • Lexeo Therapeutics' Shares Outstanding (Weighted Average) fell 99.74% to $1.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.6 million, marking a year-over-year decrease of 99.74%. This contributed to the annual value of $1.6 million for FY2022, which is N/A changed from last year.
  • Lexeo Therapeutics' Shares Outstanding (Weighted Average) amounted to $1.6 million in Q3 2023, which was down 99.74% from $1.6 million recorded in Q2 2023.
  • Over the past 5 years, Lexeo Therapeutics' Shares Outstanding (Weighted Average) peaked at $1.6 million during Q3 2022, and registered a low of $1.6 million during Q1 2023.